Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Plos One|June 1, 2016
Generation of Functional Beta-Like Cells from Human Exocrine PancreasMaria J Lima, Kenneth R Muir, Hilary M Docherty, et al.
Diabetologia|March 27, 2015
Islet transplantation from a nationally funded UK centre reaches socially deprived groups and improves metabolic outcomesShareen Forbes, Neil W A McGowan, Kirsty Duncan, et al.
Plos One|October 13, 2015
Krüppel-Like Factor 4 Overexpression Initiates a Mesenchymal-to-Epithelial Transition and Redifferentiation of Human Pancreatic Cells following Expansion in Long Term Adherent CultureKenneth R Muir, Maria João Lima, Hilary M Docherty, et al.
ACR Open Rheumatology|November 29, 2019
Binding Immunoglobulin Protein (BIP) Inhibits TNF-α-Induced Osteoclast Differentiation and Systemic Bone Loss in an Erosive Arthritis ModelMario M Zaiss, Christopher Hall, Neil W A McGowan, et al.
Diabetes|April 24, 2013
Suppression of epithelial-to-mesenchymal transitioning enhances ex vivo reprogramming of human exocrine pancreatic tissue toward functional insulin-producing β-like cellsMaria João Lima, Kenneth R Muir, Hilary M Docherty, et al.
Cytotherapy|July 5, 2017
Development, functional characterization and validation of methodology for GMP-compliant manufacture of phagocytic macrophages: A novel cellular therapeutic for liver cirrhosisAlasdair R Fraser, Chloe Pass, Paul Burgoyne, et al.
Cytotherapy|September 7, 2015
Phenotypic and functional characterization of macrophages with therapeutic potential generated from human cirrhotic monocytes in a cohort studyJoanna K Moore, Alison C Mackinnon, Dvina Wojtacha, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 10, 2010
Neighbor of Brca1 gene (Nbr1) functions as a negative regulator of postnatal osteoblastic bone formation and p38 MAPK activityCaroline A Whitehouse, Sarah Waters, Katie Marchbank, et al.
Cytotherapy|August 24, 2020
Pancreas-derived mesenchymal stromal cells share immune response-modulating and angiogenic potential with bone marrow mesenchymal stromal cells and can be grown to therapeutic scale under Good Manufacturing Practice conditionsKayleigh L Thirlwell, David Colligan, Joanne C Mountford, et al.
Frontiers in Immunology|July 16, 2024
EBV T-cell immunotherapy generated by peptide selection has enhanced effector functionality compared to LCL stimulationRachel S Cooper, Catherine Sutherland, Linda M Smith, et al.
Pageof 3